This is a preview of subscription content, log in via an institution to check access.
Reference
NICE. NICE draft guidance provides Cancer Drugs Fund first in Europe access to new treatment option for advanced breast cancer Internet Document : 20 Apr 2021. Available from: URL: https://www.nice.org.uk/
Rights and permissions
About this article
Cite this article
NICE: trastuzumab deruxtecan recommended in draft guidance. PharmacoEcon Outcomes News 877, 36 (2021). https://doi.org/10.1007/s40274-021-7685-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7685-0